Skip to main content
AAPL+0.69%MSFT+0.96%GOOGL-2.70%NVDA+3.63%AMZN+1.69%SPCX-7.69%TSM-9.36%AVGO-12.19%META+1.21%TSLA+1.46%LLY-0.30%WMT+1.52%JPM-2.98%BRK-B-0.36%V-0.09%SKHY-13.11%AMD-13.25%MU+2.48%XOM+0.67%JNJ+1.25%MA-0.06%ABBV+0.94%ASMLa+0.68%COST+0.76%1398.HK+0.25%KO+0.94%CVX+0.91%0700.HK-1.26%PG+0.91%CSCO-4.29%0939.HK0.00%HD+0.72%3988.HK-1.13%BAC-3.15%1816.HK+3.45%GE-2.87%0857.HK-0.49%ORCL-8.48%UNH+2.85%1288.HK-0.45%PM-1.26%0005.HK-3.08%NVS-0.50%HSBA.L+0.29%INTC-7.97%AZN-0.60%MS-5.32%RTX-1.58%ORp+0.16%TMO-2.79%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%PLNJPY0.00%GBPZAR0.00%USDZAR0.00%USDPLN0.00%EURNZD0.00%AUDCHF0.00%EURSEK0.00%GBPUSD0.00%GBPCHF0.00%USDDKK0.00%USDHKD0.00%GBPCAD0.00%NZDCAD0.00%GBPNZD0.00%GBPAUD0.00%EURCAD0.00%EURJPY0.00%EURNOK0.00%EURUSD0.00%CADCHF0.00%CADJPY0.00%CHFJPY0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%USDSGD0.00%EURPLN0.00%NZDJPY0.00%CHFNOK0.00%EURDKK0.00%NZDMXN0.00%GBPSGD0.00%GAGUSD0.00%W10.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+1.08%ETHUSD+71.01%USDTUSD+0.13%XRPUSD+61.26%SOLUSD+68.72%TRXUSDT+0.23%ZECUSDT+2.21%XMRUSDT-0.09%DOGEUSD+69.80%LINKUSD+2.45%XLMUSD-0.44%BCHUSDT-0.15%LTCUSD+68.40%UNIUSD-0.57%TONUSD+79.92%SUIUSD+1.82%HBARUSDT-0.07%TAOUSDT+2.85%AAVEUSD+1.52%ONDOUSDT+1.26%DOTUSDT+1.46%ICPUSDT+2.21%WLDUSDT+2.88%ARBUSDT+2.88%ATOMUSDT+1.90%INJUSDT+5.70%STXUSDT+4.18%PYTHUSDT+3.71%TIAUSDT+3.05%FETUSDT-0.13%SEIUSDT+0.59%JUPUSDT+2.33%GRTUSDT+0.86%OPUSDT+2.97%IOTAUSDT+2.14%POLUSDT+0.15%WIFUSDT+2.36%AXSUSDT+0.17%EOSUSDT+0.99%IMXUSDT+0.09%FARTCOINUSDT+1.61%GALAUSDT+3.50%DYDXUSDT+0.84%ORDIUSDT+2.72%NOTUSDT+1.19%RONINUSDT+1.91%AAPL+0.69%MSFT+0.96%GOOGL-2.70%NVDA+3.63%AMZN+1.69%SPCX-7.69%TSM-9.36%AVGO-12.19%META+1.21%TSLA+1.46%LLY-0.30%WMT+1.52%JPM-2.98%BRK-B-0.36%V-0.09%SKHY-13.11%AMD-13.25%MU+2.48%XOM+0.67%JNJ+1.25%MA-0.06%ABBV+0.94%ASMLa+0.68%COST+0.76%1398.HK+0.25%KO+0.94%CVX+0.91%0700.HK-1.26%PG+0.91%CSCO-4.29%0939.HK0.00%HD+0.72%3988.HK-1.13%BAC-3.15%1816.HK+3.45%GE-2.87%0857.HK-0.49%ORCL-8.48%UNH+2.85%1288.HK-0.45%PM-1.26%0005.HK-3.08%NVS-0.50%HSBA.L+0.29%INTC-7.97%AZN-0.60%MS-5.32%RTX-1.58%ORp+0.16%TMO-2.79%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%PLNJPY0.00%GBPZAR0.00%USDZAR0.00%USDPLN0.00%EURNZD0.00%AUDCHF0.00%EURSEK0.00%GBPUSD0.00%GBPCHF0.00%USDDKK0.00%USDHKD0.00%GBPCAD0.00%NZDCAD0.00%GBPNZD0.00%GBPAUD0.00%EURCAD0.00%EURJPY0.00%EURNOK0.00%EURUSD0.00%CADCHF0.00%CADJPY0.00%CHFJPY0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%USDSGD0.00%EURPLN0.00%NZDJPY0.00%CHFNOK0.00%EURDKK0.00%NZDMXN0.00%GBPSGD0.00%GAGUSD0.00%W10.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+1.08%ETHUSD+71.01%USDTUSD+0.13%XRPUSD+61.26%SOLUSD+68.72%TRXUSDT+0.23%ZECUSDT+2.21%XMRUSDT-0.09%DOGEUSD+69.80%LINKUSD+2.45%XLMUSD-0.44%BCHUSDT-0.15%LTCUSD+68.40%UNIUSD-0.57%TONUSD+79.92%SUIUSD+1.82%HBARUSDT-0.07%TAOUSDT+2.85%AAVEUSD+1.52%ONDOUSDT+1.26%DOTUSDT+1.46%ICPUSDT+2.21%WLDUSDT+2.88%ARBUSDT+2.88%ATOMUSDT+1.90%INJUSDT+5.70%STXUSDT+4.18%PYTHUSDT+3.71%TIAUSDT+3.05%FETUSDT-0.13%SEIUSDT+0.59%JUPUSDT+2.33%GRTUSDT+0.86%OPUSDT+2.97%IOTAUSDT+2.14%POLUSDT+0.15%WIFUSDT+2.36%AXSUSDT+0.17%EOSUSDT+0.99%IMXUSDT+0.09%FARTCOINUSDT+1.61%GALAUSDT+3.50%DYDXUSDT+0.84%ORDIUSDT+2.72%NOTUSDT+1.19%RONINUSDT+1.91%
AL

Alkermes plc (ALKS)

NASDAQ • Healthcare

$44.94
-$1.24 (-2.7%)
Market closed

Last close at November 20, 2026 at 21:00 UTC

Open$45.79
Day Range$44.83 - $46.89
Avg. Volume (3M)1.5M
Market Cap$7.5B
P/E Ratio14980.0
52 Week Range
$27$55.67

Metrics Over Time

Where the Money Goes

Q3 2026
Revenueeverything earned$480.1M100%
Gross Profitminus cost of goods$385.9M80%
Operating Incomeminus R&D and overhead$36M8%
Net Incomeminus taxes and the rest$16.2M3%

In plain terms: out of every $100 in revenue, Alkermes plc keeps $3 as net profit.

Fundamentals & Financials

Revenue (TTM)
$1.7B
Net Income (TTM)
-$351K
EPS (TTM)
$0.003
ROA (TTM)
-0.0079%
Current Ratio
2.42
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+29.8%Q2 2026-$0.4
+2650.1%Q3 2026$0.7
+210.1%Q4 2026$0.09

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q4 2026
Beat +210.1%

Alkermes topped expectations on both EPS and revenue in the third fiscal quarter of 2026, reported November 3, 2026, as revenue rose ~22% to roughly $480 million (up from about $394 million a year ago), with EPS of $0.09 topping the -$0.08 estimate by $0.17 and revenue of $480.1 million topping the $463.5 million estimate, +3.6%. Profitability metrics showed a gross margin of ~80% and an operating margin of ~8%, with operating income of about $36 million. Despite the higher revenue, net income fell ~80% year over year to roughly $16 million (down from about $83 million), and EPS was down ~82% from $0.49 a year ago. The company generated about $93.5 million of operating cash flow in the quarter. For the next period, consensus calls for EPS of -$0.13 on revenue of $467.0 million.

View full earnings history

About Alkermes plc

Alkermes plc is a biotechnology company listed on NASDAQ as ALKS that develops and commercializes central nervous system medicines and related drug-delivery capabilities. Its portfolio spans schizophrenia, addiction, bipolar disorder, and sleep disorders, and it generated $1.5 billion of revenue in FY2025.

Name
Alkermes plc
CEO
Blair Jackson
Industry
Healthcare
Year Founded
1987
Employees
2,050

Today's Snapshot

AI-generated

ALKS closed 2.7% lower at 44.94, while its sector was flat.

Trading Volume

Below 10d avg (1.4M)

1M

vs S&P 500 Today

Outperforming Market

+0.80%

Updated: November 20, 2026 at 21:16 UTC

Technical Indicators

2 Buy3 Neutral3 Sell
ALKS displays a neutral technical stance with mixed moving-average signals: short-term averages sit above the price while the 50- and 200-day levels are supportive, producing a split bias. Momentum and oscillators are broadly neutral, with RSI near the midpoint and MACD slightly positive but short-term momentum mildly negative. Trend strength is limited on the ADX and volatility is moderate, while on-balance-volume shows selling pressure that offsets some positive moving-average context. The classic pivot sits above current levels, offering nearby resistance. Technical takeaway: Neutral — indicators are balanced between modest support from longer averages and short-term weakness.
All signals
  • EMA (5 indicators)$40.33 - $46.01
    Sell
  • RSI (14)48.50
    Neutral
  • Stochastic %K (14, 3, 3)45.39
    Neutral
  • MACD Level (12, 26)0.67
    Neutral
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.